title: Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits.
abstract: Whether hypercholesterolemia (HC) can induce proarrhythmic neural and electrophysiological remodeling is unclear. We fed rabbits with either high cholesterol (HC, n=10) or standard (S, n=10) chows for 12 weeks (protocol 1), and with HC (n=12) or S (n=10) chows for 8 weeks (protocol 2). In protocol 3, 10 rabbits were fed with various protocols to observe the effects of different serum cholesterol levels. Results showed that the serum cholesterol levels were 2097+/-288 mg/dL in HC group and 59+/-9 mg/dL in S group for protocol 1 and were 1889+/-577 mg/dL in HC group and 50+/-21 mg/dL in S group for protocol 2. Density of growth-associated protein 43- (GAP43) and tyrosine hydroxylase- (TH) positive nerves in the heart was significantly higher in HC than S in protocol 1. Compared with S, HC rabbits had longer QTc intervals, more QTc dispersion, longer action potential duration, increased heterogeneity of repolarization and higher peak calcium current (ICa) density (14.0+/-3.1 versus 9.1+/-3.4 pA/pF; P<0.01) in protocol 1 and 2. Ventricular fibrillation was either induced or occurred spontaneously in 9/12 of hearts of HC group and 2/10 of hearts in S group in protocol 2. Protocol 3 showed a strong correlation between serum cholesterol level and nerve density for GAP43 (R2=0.94; P<0.001) and TH (R2=0.91; P<0.001). We conclude that HC resulted in nerve sprouting, sympathetic hyperinnervation, and increased ICa. The neural and electrophysiological remodeling was associated with prolonged action potential duration, longer QTc intervals, increased repolarization dispersion, and increased ventricular vulnerability to fibrillation.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University School of Medicine, Taiwan, Republic of China.
authors.forename: Yen-Bin
authors.initials: YB
authors.lastname: Liu
authors.forename: Chau-Chung
authors.initials: CC
authors.lastname: Wu
authors.forename: Long-Sheng
authors.initials: LS
authors.lastname: Lu
authors.forename: Ming-Jai
authors.initials: MJ
authors.lastname: Su
authors.forename: Chii-Wann
authors.initials: CW
authors.lastname: Lin
authors.forename: Shien-Fong
authors.initials: SF
authors.lastname: Lin
authors.forename: Lan S
authors.initials: LS
authors.lastname: Chen
authors.forename: Michael C
authors.initials: MC
authors.lastname: Fishbein
authors.forename: Peng-Sheng
authors.initials: PS
authors.lastname: Chen
authors.forename: Yuan-Teh
authors.initials: YT
authors.lastname: Lee
mesh_terms: D000200:Action Potentials; D000818:Animals; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary; D003331:Coronary Vessels / Q000473:pathology; D004195:Disease Models, Animal; D004198:Disease Susceptibility / Q000503:physiopathology; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D019922:GAP-43 Protein / Q000096:biosynthesis; D006321:Heart / Q000294:innervation* / Q000503:physiopathology; D006329:Heart Conduction System / Q000503:physiopathology; D006937:Hypercholesterolemia / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D014280:Triglycerides / Q000097:blood; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis; D014693:Ventricular Fibrillation / Q000209:etiology / Q000503:physiopathology*; D020257:Ventricular Remodeling
chemical_list: D002791:Cholesterol, Dietary; D019922:GAP-43 Protein; D014280:Triglycerides; D002784:Cholesterol; D014446:Tyrosine 3-Monooxygenase